Amoxicillin, Amoxicillin With Clavulanic Acid, Cefalexin, Doxycycline, Roxithromycin
Recommended · restricted Infectious diseaseAuthority RequiredNot applicable line
Restriction of repeat prescriptions for antibiotics to encourage antimicrobial stewardship and align PBS listings with Therapeutic Guidelines (version 16) indications, reducing inadvertent repeat prescribing.
1
Submissions
1 resub
2019–19
On the record
—
ICER range
Not modelled
Cost basis
Access path
- Aug 2019Recommended · restricted
- PBS listing · Authority Required
RecommendedDeferredNot recommended
From the public summary
PBAC outcome
4.1 The PBAC considered the changes proposed in the Request for advice from the Minister’s delegate and recommended changes to the antibiotic PBS items which allow prescriptions for amoxicillin, amoxicillin and clavulanic acid, cefalexin, and roxithromycin as below (and detailed in section 5): implementing new Authority Required (STREAMLINED) listings to enable access to antibiotic prescriptions with repeats for indications where clinically indicated as …PSD · Aug 2019
2 Respondents included the Royal Australian College of General Practitioners, Australian Medical Association and the Australian College of Rural and Remote Medicine, amongst other professional organisations. 2PSD · Aug 2019
Cost-effectiveness
No economic model or ICER calculated; this is a policy/stewardship review with administrative/listing changes only.
Decision context
PopulationAustralian patients requiring antibiotic treatment for indications listed in Therapeutic Guidelines (version 16); the review specifically targeted the top five antibiotics (amoxicillin, amoxicillin with clavulanic acid, cefalexin, doxycycline, roxithromycin) representing 78% of repeat antibiotic prescriptions on the PBS.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Aug 2019 | Recommended · restricted | — | — | Other |